TWA
IMMU

TCI Wealth Advisors’s Immunomedics Inc IMMU Stock Holding History

TCI Wealth Advisors’s Portfolio IMMU Stock Details IMMU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-6,000
Closed -$125K – 1752
2018
Q3 		$125K Hold
6,000
– – 0.05% 208
2018
Q2 		$142K Buy
6,000
+1,000
+20% +$20.1K 0.06% 181
2018
Q1 		$73K Buy
5,000
+3,000
+150% +$49K 0.03% 268
2017
Q4 		$32K Sell
2,000
-4,000
-67% -$47.2K 0.01% 408
2017
Q3 		$84K Buy
6,000
+1,000
+20% +$9.97K 0.04% 236
2017
Q2 		$44K Buy
+5,000
New +$35.1K 0.02% 331

Other funds holding IMMU

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
RM
RP Management New York $139M AUM 37.98% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

TCI Wealth Advisors's IMMU Position: Q4 2018 in Review

TCI Wealth Advisors sold out of Immunomedics Inc (IMMU) in Q4 2018, closing a stake of 6,000 shares — an estimated $125K sold.

TCI Wealth Advisors first reported a position in IMMU in Q2 2017 and held it in 6 quarters. The position peaked at $142K in Q2 2018. 205 funds tracked by Wall St. Rank hold IMMU as of Q4 2018.

  • TCI Wealth Advisors reported no remaining Immunomedics Inc position as of Q4 2018 after selling out during the quarter.
  • TCI Wealth Advisors sold 6,000 Immunomedics Inc shares in Q4 2018, an estimated $125K.
  • TCI Wealth Advisors first reported a position in Immunomedics Inc in Q2 2017 and held it in 6 quarters.
  • TCI Wealth Advisors's Immunomedics Inc position peaked at $142K in Q2 2018.
  • 205 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2018.

Based on TCI Wealth Advisors's 13F filing for Q4 2018, filed 17 Jan 2019.